Spatial agent-based modeling and interpretable machine learning identify determinants of combination-therapy response in HER2-heterogeneous breast cancer
- Open access
The AI brief for this paper is being written. Open it in JClub to read the paper with the brief as soon as it lands.
Read the brief in JClub →